Citadel Advisors
DNA icon

Citadel Advisors’s Ginkgo Bioworks DNA Stock Holding History

Citadel Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$327K Sell
53,300
-18,330
-26% -$152K ﹤0.01% 10290
2025
Q4 		$595K Buy
71,630
+26,892
+60% +$290K ﹤0.01% 8611
2025
Q3 		$652K Buy
44,738
+32,840
+276% +$393K ﹤0.01% 8502
2025
Q2 		$134K Sell
11,898
-57,196
-83% -$443K ﹤0.01% 11063
2025
Q1 		$394K Sell
69,094
-60,874
-47% -$620K ﹤0.01% 8999
2024
Q4 		$1.28M Buy
129,968
+67,290
+107% +$577K ﹤0.01% 6533
2024
Q3 		$511K Buy
62,678
+46,863
+296% +$470K ﹤0.01% 8219
2024
Q2 		$211K Buy
15,815
+1,865
+13% +$55.6K ﹤0.01% 9810
2024
Q1 		$647K Sell
13,950
-30
-0.2% -$1.55K ﹤0.01% 7816
2023
Q4 		$945K Buy
13,980
+730
+6% +$44.7K ﹤0.01% 6791
2023
Q3 		$959K Buy
13,250
+4,437
+50% +$355K ﹤0.01% 6635
2023
Q2 		$656K Buy
8,813
+2,518
+40% +$149K ﹤0.01% 7341
2023
Q1 		$335K Sell
6,295
-1,414
-18% -$89.6K ﹤0.01% 9154
2022
Q4 		$521K Sell
7,709
-339
-4% -$31.2K ﹤0.01% 8151
2022
Q3 		$1M Sell
8,048
-1,115
-12% -$133K ﹤0.01% 6985
2022
Q2 		$872K Buy
9,163
+2,653
+41% +$324K ﹤0.01% 7335
2022
Q1 		$1.05M Sell
6,510
-10,255
-61% -$2M ﹤0.01% 7579
2021
Q4 		$5.57M Buy
16,765
+12,155
+264% +$5.77M ﹤0.01% 4107
2021
Q3 		$2.14M Buy
+4,610
New +$2.24M ﹤0.01% 6176

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's DNA Position: Q3 2025 in Review

Citadel Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 10,114 shares — an estimated $121K sold.

Citadel Advisors first reported a position in DNA in Q3 2021 and held it in 13 quarters. The position peaked at $12M in Q3 2021. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • Citadel Advisors reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,114 Ginkgo Bioworks shares in Q3 2025, an estimated $121K.
  • Citadel Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 13 quarters.
  • Citadel Advisors's Ginkgo Bioworks position peaked at $12M in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.